Anti-VEGF: A Vision-Saving Treatment
Understanding Anti-VEGF Therapy
This section explains what anti-VEGF therapy is and why it matters.
Anti-VEGF stands for anti-vascular endothelial growth factor, a treatment that blocks VEGF, the protein that promotes new blood vessel growth. Excessive VEGF in the eye can cause fragile vessels to leak fluid or blood, leading to swelling and vision damage.
Anti-VEGF medications bind to VEGF, preventing it from triggering abnormal vessel formation beneath the retina. By halting this growth, the therapy reduces swelling, stabilizes vision, and can improve clarity while allowing VEGF to continue its normal healing role elsewhere in the body.
Diabetic and Vascular Conditions Treated with Anti-VEGF
Anti-VEGF therapy is widely used to manage retinal problems caused by diabetes and vascular blockages.
DME is a complication of diabetes that causes fluid to leak into the macula, leading to swelling and blurry vision. Anti-VEGF injections reduce leakage and swelling, helping preserve vision.
A blood clot can block a retinal vein, causing fluid buildup and swelling. Anti-VEGF therapy helps reduce swelling and improve vision.
- Branch Retinal Vein Occlusion (BRVO) affects only part of the field of vision.
- Central Retinal Vein Occlusion (CRVO) involves the main retinal vein and can lead to widespread vision loss.
Age-Related and Degenerative Conditions Treated with Anti-VEGF
Several degenerative eye diseases respond well to anti-VEGF injections.
Wet AMD occurs when abnormal blood vessels grow under the macula and leak fluid, leading to rapid vision loss. Anti-VEGF treatments slow vessel growth and help preserve central vision.
RAP is a form of wet AMD in which abnormal vessels form within the retinal layers. Anti-VEGF therapy reduces leakage and limits further vessel growth.
PCV involves polyp-like blood vessels beneath the retina that can leak or bleed. Anti-VEGF injections lessen vessel activity and improve vision outcomes.
High myopia can trigger abnormal vessels under the retina, causing fluid leakage and distorted vision. Anti-VEGF therapy helps stop this growth and protect central sight.
Sometimes abnormal vessel growth occurs without a clear cause. Anti-VEGF treatment reduces leakage and stabilizes vision in these cases.
Inflammatory and Infectious Conditions Treated with Anti-VEGF
When inflammation or infection leads to retinal swelling or abnormal vessels, anti-VEGF therapy can provide relief.
Uveitis can cause macular edema. If other treatments do not work, anti-VEGF injections can reduce swelling and help preserve vision.
Toxoplasmosis can create retinal lesions that trigger abnormal vessel growth. Anti-VEGF therapy manages these secondary effects by limiting leakage.
The Anti-VEGF Treatment Process
Knowing what to expect during treatment can reduce anxiety and support good results.
Before the injection, the eye is disinfected and numbed with anesthetic drops. A small speculum keeps the eyelids open while the medication is injected through the sclera into the vitreous gel. The injection takes only seconds and usually causes mild pressure, not pain.
Most patients begin with three monthly injections, followed by intervals of four to six weeks that may be extended as the eye stabilizes. Regular imaging, such as optical coherence tomography, guides the schedule and ensures the best possible outcome.
The visit is designed for comfort and safety. Key steps include:
- Cleaning: The eye and surrounding skin are disinfected.
- Anesthesia: Numbing drops or a local anesthetic prevent discomfort.
- Stabilization: A speculum gently holds the eye open during the injection.
The entire appointment usually lasts 10 to 15 minutes, and any mild irritation, blurred vision, or floaters typically improve within a day or two.
Understanding Anti-VEGF Medications
Several medications block VEGF. Each option has unique features, and the best choice depends on your condition and needs.
Eylea targets VEGF and a similar protein to limit vessel growth and fluid leakage.
- Benefits: Many patients need fewer injections over time, and a higher-dose version may offer longer-lasting effects.
- Schedule: Injections are often given every eight weeks after an initial loading phase.
- Side effects: Usually mild, such as temporary eye irritation.
Lucentis was designed specifically for eye diseases and has a proven safety record.
- Benefits: Effective for wet AMD and other retinal disorders.
- Schedule: Typically every four to eight weeks, based on response.
- Side effects: Mild irritation or redness is possible.
Originally developed for cancer, Avastin works similarly to Lucentis in the eye.
- Benefits: An affordable option with strong results for retinal disease.
- Schedule: Injections are usually every four to six weeks.
- Side effects: Rare but can include infection or inflammation.
Beovu is a newer medication that binds VEGF in a slightly different way.
- Benefits: May allow eight to twelve weeks between injections.
- Schedule: Fewer injections can offer added convenience.
- Side effects: Rare cases of inflammation have been reported.
Vabysmo targets VEGF and another protein involved in vessel growth.
- Benefits: Durable results may mean injections every eight to twelve weeks.
- Schedule: Frequency depends on individual response.
- Side effects: Similar to other anti-VEGF drugs, with occasional inflammation.
Mucugen binds VEGF to prevent abnormal vessel growth and leakage.
- Benefits: Offers a different approach, though it is used less often today.
- Schedule: Injections are generally every six weeks.
- Side effects: Mild irritation or redness can occur.
Frequently Asked Questions
The following questions address common concerns about anti-VEGF therapy.
Anti-VEGF injections have been a major breakthrough in retinal care. They stabilize vision in most patients and often improve clarity when treatment starts early and is maintained as recommended.
Long-term use is generally safe when managed by an experienced retina specialist. The risk of serious complications remains low with regular monitoring and follow-up.
If you notice increased eye pain, redness, unexpected vision changes, or significant swelling, contact your retina specialist right away so that any issues can be assessed and treated promptly.
The duration and frequency of injections vary by individual. Many patients start with more frequent visits and transition to longer intervals once the condition stabilizes. Your retina specialist will tailor the plan to your needs.
Your Partner in Vision Care
Our retina specialists are committed to protecting and enhancing your sight with personalized anti-VEGF therapy. If you have questions about treatment or wish to discuss your eye health, we look forward to helping you see your best.
Dr. Linares is one of the best. He always has an optimistic view and does his best to help his parents see the brightest outcome. His staff are some of the bests around.
April Kirk
Great doctor, wonderful staff. I've been a patient of Dr. Kleiner for 14 years. He’s done a great job of preserving my vision.
Joe
Dr. Kleiner is the very best! I have been going there for 8 years now and always receive excellent treatment. His staff is very friendly and helpful as well. I can’t imagine ever going anywhere else.
Frank Iannuzzi
Staff was very friendly and efficient. I was a new patient add on and it didn’t feel that way.
F.T
Dr. Hugo Linares is an excellent eye surgeon. He operated on my detached retina six years ago. Highly recommend him for all retina surgeries. Truly professional. God bless him.
Reggie Timonera